Marijuana producer Canopy Growth has lost two top executives this week.
The Canadian company’s chief commercial officer of recreational cannabis, Dave Bigioni, and chief operating officer Andre Fernandez have parted ways.

“Both decisions were made mutually,” Jordan Sinclair, vice president of communications, confirmed in an email sent to Marijuana Business Daily.

“Canopy has engaged an executive search firm to fill the roles of COO and CCO to lead the business forward.”

Before coming to Canopy Growth, Bigioni had worked as the vice president of marketing and sales at Molson Coors Canada. He oversaw a team of roughly 300 people at Canopy “between brand marketing & innovation, events, digital marketing, learning & development, consumer insights & analytics, sales and creative,” according to a biography that was on the company’s website but has since been deleted.

It was on LinkedIn that Fernandez announced that he was leaving the company. He joined Canopy in 2016 and was responsible for creating and executing the company’s operational strategy.

Fernandez had said his primary focus was “building a world-class globally integrated supply chain that scales and innovates rapidly to deliver comprehensive value to customers and shareholders,” in his biography.

CEO David Klein wrote in an e-mail to MJBizDaily last month that he would share details of the company’s “new vision” after the company’s next earnings report.

“For a long time, Canopy has prioritized doing things first, but going forward, we’ll be focused on doing things the best in the markets and in the product formats that show the greatest promise,” he said.

Disclaimer: We have no position in Canopy Growth Corp. (NYSE: CGC) and have not been compensated for this article.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Colorado Wants to Make Its Marijuana Industry More Eco-Friendly
31 January 2020
Researchers Find That Marijuana Legalization Reduces Alcohol Use
06 December 2017
Aurora Cannabis Soars After Buying Whistler Medical Marijuana
15 January 2019